研究業績
Achievement

2024年の研究業績

1. 原著

  1. Muraoka S, Baba T, Akazawa T, Katayama KI, Kusumoto H, Yamashita S, Kohjimoto Y, Iwabuchi S, Hashimoto S, Hara I, Inoue N. Tumor-derived lactic acid promotes acetylation of histone H3K27 and differentiation of IL-10-producing regulatory B cells through direct and indirect signaling pathways. Int J Cancer 2024 Oct 31;156(4):840-852 doi: 10.1002/ijc.35229. PMID: 39482832
  2. Tasaki Y, Tsujimoto H, Yokoyama T, Sugimoto N, Kitajima S, Fujii H, Hidaka Y, Kato N, Maruyama S, Inoue N, Wada T. Case report: A family of atypical hemolytic uremic syndrome involving a CFH::CFHR1 fusion gene and CFHR3-1-4-2 gene duplication. Front Immunol. 2024 Mar 8;15:1360855. doi: 10.3389/fimmu.2024.1360855. eCollection 2024. PMID: 38524137
  3. Osawa K, Yamamoto S, Yamano Y, Kita A, Okamoto K, Kato N, Tatematsu Y, Kojima F, Ohya M, Hara S, Murata SI, Inoue N, Maruyama S, Araki SI. Overlapping Atypical Hemolytic Uremic Syndrome and C3 Glomerulopathy with Mutation in CFI in a Japanese Patient: A Case Report. Intern Med. 2024 Jun15;63(12): 1777-1782. doi: 10.2169/internalmedicine.2713-23. PMID: 37926536

2. 総説

英文

和文

  1. 井上徳光:補体検査の基礎と発展 臨床検査 補体をめぐる話題 2024; 68 (1):56-64
  2. 井上徳光:補体経路と制御機構 腎と透析 2024; 97 (1): 21-27
  3. 大谷克城、井上徳光、若宮伸隆 補体関連検査 腎と透析 2024; 97 (1): 50-55
  4. 辻本弘、井上徳光 補体と凝固のクロストークー補体介在性疾患の分子メカニズムー 臨床血液 2024; 65 (6): 576-583
トップへ